Melospeech Inc. Awarded New AAC Contract With San Diego Regional Center
The Californer/10346943

TEMECULA, Calif. - Californer -- Melospeech Inc., a Woman-owned provider of speech therapy, occupational therapy, and early childhood education services, has been awarded an Augmentative and Alternative Communication (AAC) contract with the California San Diego Regional Center. AAC refers to tools and strategies — such as picture boards and speech-generating devices — that give a voice to individuals who cannot yet speak or need support communicating, helping them express their needs, build relationships, and participate in everyday life.  The San Diego Regional Center, a nonprofit, has served individuals with developmental disabilities and their families across San Diego and Imperial Counties since 1969, currently supporting more than 48,000 people through a staff of 1,000 and an annual budget of $1.2 billion.  The contract further extends Melospeech's reach across San Diego county, where the company serves children with developmental delays and disabilities through in-home, community-based, and virtual care.

More on The Californer

• Governor Newsom welcomes first public preview of California Science Center's new Air and Space Center ahead of November opening
• California: Governor Newsom awards $38.2 million to help tribes expand housing and homelessness solutions
• GreenSight and IQ Reseller Partner to Bring AI Pricing to the Secondary Electronics Market
• In the years since Dobbs, California continues to stand firm as a strong reproductive freedom state
• The Calida Group Announces Promotion of Joshua Nelson to President, Advancing Next Phase of National Growth

Founded in 2021 by Dr. Givona Sandiford, CCC-SLP, Melospeech now operates across California, New York, and Tennessee, earning recognition along the way from the Gold Stevie® Awards, Fast Company's Best Workplaces for Innovators 2025 (#35), and the WomELLE Social Impact Business of the Year. With 96% of children in its care showing meaningful progress toward their therapy goals in 2025.

Website: www.melospeech.com